A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination

In this report, we examine the case of a patient who developed antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after receiving the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. This is a case of a 62-year-old female who received the first dose of COVID-19 vaccine in J...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Yafeai, Zaki, Horn, Benjamin Joesph M, Terraccaine, William, Jose, Alvin, Krishnan, Prathik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010006/
https://www.ncbi.nlm.nih.gov/pubmed/35444915
http://dx.doi.org/10.7759/cureus.23162
_version_ 1784687389340336128
author Al-Yafeai, Zaki
Horn, Benjamin Joesph M
Terraccaine, William
Jose, Alvin
Krishnan, Prathik
author_facet Al-Yafeai, Zaki
Horn, Benjamin Joesph M
Terraccaine, William
Jose, Alvin
Krishnan, Prathik
author_sort Al-Yafeai, Zaki
collection PubMed
description In this report, we examine the case of a patient who developed antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after receiving the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. This is a case of a 62-year-old female who received the first dose of COVID-19 vaccine in July 2021 before presenting a few weeks later with migrating polyarthralgia and hemoptysis. Autoimmune workup was positive for ANCA against proteinase 3 (PR3).
format Online
Article
Text
id pubmed-9010006
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-90100062022-04-19 A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination Al-Yafeai, Zaki Horn, Benjamin Joesph M Terraccaine, William Jose, Alvin Krishnan, Prathik Cureus Internal Medicine In this report, we examine the case of a patient who developed antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after receiving the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. This is a case of a 62-year-old female who received the first dose of COVID-19 vaccine in July 2021 before presenting a few weeks later with migrating polyarthralgia and hemoptysis. Autoimmune workup was positive for ANCA against proteinase 3 (PR3). Cureus 2022-03-14 /pmc/articles/PMC9010006/ /pubmed/35444915 http://dx.doi.org/10.7759/cureus.23162 Text en Copyright © 2022, Al-Yafeai et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Al-Yafeai, Zaki
Horn, Benjamin Joesph M
Terraccaine, William
Jose, Alvin
Krishnan, Prathik
A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination
title A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination
title_full A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination
title_fullStr A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination
title_full_unstemmed A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination
title_short A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination
title_sort case of antineutrophil cytoplasmic antibodies (anca)-associated vasculitis post covid-19 vaccination
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010006/
https://www.ncbi.nlm.nih.gov/pubmed/35444915
http://dx.doi.org/10.7759/cureus.23162
work_keys_str_mv AT alyafeaizaki acaseofantineutrophilcytoplasmicantibodiesancaassociatedvasculitispostcovid19vaccination
AT hornbenjaminjoesphm acaseofantineutrophilcytoplasmicantibodiesancaassociatedvasculitispostcovid19vaccination
AT terraccainewilliam acaseofantineutrophilcytoplasmicantibodiesancaassociatedvasculitispostcovid19vaccination
AT josealvin acaseofantineutrophilcytoplasmicantibodiesancaassociatedvasculitispostcovid19vaccination
AT krishnanprathik acaseofantineutrophilcytoplasmicantibodiesancaassociatedvasculitispostcovid19vaccination
AT alyafeaizaki caseofantineutrophilcytoplasmicantibodiesancaassociatedvasculitispostcovid19vaccination
AT hornbenjaminjoesphm caseofantineutrophilcytoplasmicantibodiesancaassociatedvasculitispostcovid19vaccination
AT terraccainewilliam caseofantineutrophilcytoplasmicantibodiesancaassociatedvasculitispostcovid19vaccination
AT josealvin caseofantineutrophilcytoplasmicantibodiesancaassociatedvasculitispostcovid19vaccination
AT krishnanprathik caseofantineutrophilcytoplasmicantibodiesancaassociatedvasculitispostcovid19vaccination

Ejemplares similares